Target Name: PLEKHB2
NCBI ID: G55041
Review Report on PLEKHB2 Target / Biomarker Content of Review Report on PLEKHB2 Target / Biomarker
PLEKHB2
Other Name(s): EVT2 | Pleckstrin homology domain-containing family B member 2 | FLJ20783 | Pleckstrin homology domain-containing family B member 2 (isoform 11) | Evectin-2 | pleckstrin homology domain containing B2 | PH domain-containing family B member 2 | pleckstrin homology domain containing, family B (evectins) member 2 | Pleckstrin homology domain-containing family B member 2 (isoform 3) | PLEKHB2 variant 14 | evectin-2 | Pleckstrin homology domain containing B2, transcript variant 14 | PKHB2_HUMAN | Pleckstrin homology domain containing B2, transcript variant 3 | PLEKHB2 variant 3 | FLJ23679 | FLJ30436

Understanding The Functions of PLEKHB2: A Potential Drug Target

PLEKHB2 (EVT2) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the evolutionarily conserved heat shock protein (HSP) family, which are known for their ability to withstand extreme temperatures and stress conditions. PLEKHB2 is also a key regulator of the cell stress response, and has been implicated in a number of cellular processes that are important for both normal development and disease.

One of the key functions of PLEKHB2 is its role in the regulation of cellular stress. During times of stress, such as exposure to toxins or radiation, PLEKHB2 helps to ensure that cells are able to withstand damage and continue to function properly. This is done by PLEKHB2 interacting with other stress-response genes, such as those that are involved in DNA damage repair or cell death.

Another important function of PLEKHB2 is its role in the regulation of cellular signaling. PLEKHB2 is involved in a number of signaling pathways that are important for normal cellular function, including those that are involved in cell adhesion, migration, and survival. It is also involved in the regulation of ion channels and the production of reactive oxygen species (ROS), which can be damaging to cells and contribute to a number of diseases, including neurodegenerative diseases.

In addition to its role in cellular stress and signaling, PLEKHB2 is also involved in the regulation of inflammation. PLEKHB2 has been shown to play a key role in the regulation of immune cell function and the production of pro-inflammatory cytokines. This is important for the immune response and may contribute to the development of autoimmune diseases.

PLEKHB2 is also involved in the regulation of cellularApoptosis, which is the process by which cells decide when to die and are programmed to do so. This is important for the regulation of cell life cycle and may be involved in a number of diseases, including cancer.

In conclusion, PLEKHB2 (EVT2) is a protein that is involved in a number of important cellular processes that are essential for normal development and disease. Its role in the regulation of cellular stress, signaling, inflammation, and apoptosis makes it an attractive target for research and development of new drugs. Further studies are needed to fully understand the functions of PLEKHB2 and its potential as a drug target.

Protein Name: Pleckstrin Homology Domain Containing B2

Functions: Involved in retrograde transport of recycling endosomes

The "PLEKHB2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PLEKHB2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PLEKHD1 | PLEKHF1 | PLEKHF2 | PLEKHG1 | PLEKHG2 | PLEKHG3 | PLEKHG4 | PLEKHG4B | PLEKHG5 | PLEKHG6 | PLEKHG7 | PLEKHH1 | PLEKHH2 | PLEKHH3 | PLEKHJ1 | PLEKHM1 | PLEKHM1P1 | PLEKHM2 | PLEKHM3 | PLEKHN1 | PLEKHO1 | PLEKHO2 | PLEKHS1 | PLET1 | Plexin | PLG | PLGLA | PLGLB1 | PLGLB2 | PLGRKT | PLIN1 | PLIN2 | PLIN3 | PLIN4 | PLIN5 | PLK1 | PLK2 | PLK3 | PLK4 | PLK5 | PLLP | PLN | PLOD1 | PLOD2 | PLOD3 | PLP1 | PLP2 | PLPBP | PLPP1 | PLPP2 | PLPP3 | PLPP4 | PLPP5 | PLPP6 | PLPP7 | PLPPR1 | PLPPR2 | PLPPR3 | PLPPR4 | PLPPR5 | PLPPR5-AS1 | PLRG1 | PLS1 | PLS3 | PLSCR1 | PLSCR2 | PLSCR3 | PLSCR4 | PLSCR5 | PLTP | PLUT | PLVAP | PLXDC1 | PLXDC2 | PLXNA1 | PLXNA2 | PLXNA3 | PLXNA4 | PLXNB1 | PLXNB2 | PLXNB3 | PLXNC1 | PLXND1 | PM20D1 | PM20D2 | PMAIP1 | PMCH | PMCHL1 | PMCHL2 | PMEL | PMEPA1 | PMF1 | PMF1-BGLAP | PMFBP1 | PML | PMM1 | PMM2 | PMP2 | PMP22 | PMPCA